LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.003
 24.89 771.67 1808 2397 0.7540 0.6830
MN20160304_L01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 24.89 771.67 2009 2397 0.8379 0.7950
MN20160304_L01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 27.11 771.67 1884 2675 0.7043 0.6449
MN20160304_L01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 27.11 771.67 1894 2675 0.7080 0.6498
MN20160304_L01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 27.11 771.67 2109 2675 0.7884 0.7517
MN20160304_L01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 29.33 771.67 2006 2939 0.6825 0.6407
MN20160304_L01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 29.33 771.67 1994 2939 0.6784 0.6356
MN20160304_L01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 29.33 771.67 2230 2939 0.7587 0.7333
MN20160304_L01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 31.55 771.67 2136 3196 0.6682 0.6430
MN20160304_L01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 31.55 771.67 2097 3196 0.6560 0.6283
MN20160304_L01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 31.55 771.67 2312 3196 0.7232 0.7077
MN20160304_L01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 33.78 771.67 2213 3499 0.6324 0.6210
MN20160304_L01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 33.78 771.67 2187 3499 0.6249 0.6122
MN20160304_L01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 33.78 771.67 2453 3499 0.7009 0.6993
MN20160304_L01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 36.00 771.67 2370 3884 0.6101 0.6180
MN20160304_L01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 36.00 771.67 2324 3884 0.5982 0.6045
MN20160304_L01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 36.00 771.67 2617 3884 0.6737 0.6883
MN20160304_L01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 38.22 771.67 2508 4299 0.5833 0.6090
MN20160304_L01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 38.22 771.67 2475 4299 0.5756 0.6005
MN20160304_L01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 38.22 771.67 2850 4299 0.6629 0.6942
MN20160304_L01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 40.44 771.67 2676 4738 0.5648 0.6079
MN20160304_L01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 40.44 771.67 2660 4738 0.5614 0.6042
MN20160304_L01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 40.44 771.67 3014 4738 0.6361 0.6826
MN20160304_L01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 42.67 771.67 2874 5155 0.5574 0.6159
MN20160304_L01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 42.67 771.67 2824 5155 0.5477 0.6056
MN20160304_L01
H05